HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
M Fridkin Selected Research
M Fridkin Research Topics
Disease
4
Neoplasms (Cancer)
09/2006 - 02/2000
3
Parkinson Disease (Parkinson's Disease)
01/2006 - 01/2000
3
Neurodegenerative Diseases (Neurodegenerative Disease)
01/2006 - 10/2004
2
Carcinoma (Carcinomatosis)
12/2007 - 10/2001
2
Neuroblastoma
01/2006 - 01/2000
2
Alzheimer Disease (Alzheimer's Disease)
10/2004 - 01/2000
2
Breast Neoplasms (Breast Cancer)
07/2001 - 02/2000
2
Hypoglycemia (Reactive Hypoglycemia)
12/2000 - 06/2000
2
Hyperglycemia
08/2000 - 05/2000
1
Body Weight (Weight, Body)
01/2018
1
Lupus Nephritis
01/2018
1
Proteinuria
01/2018
1
Glomerulonephritis
01/2018
1
Rheumatoid Arthritis
04/2016
1
Experimental Arthritis
04/2016
1
Necrosis
04/2016
1
Hypoxia (Hypoxemia)
05/2012
1
Motor Neuron Disease (Primary Lateral Sclerosis)
10/2005
1
Huntington Disease (Huntington's Disease)
10/2004
1
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2004
1
Friedreich Ataxia (Friedreich's Ataxia)
10/2004
1
Glioblastoma (Glioblastoma Multiforme)
12/2001
1
Poisoning
02/2001
1
Ischemia
12/2000
1
Sepsis (Septicemia)
10/2000
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2000
1
Pheochromocytoma
01/2000
1
Pancreatic Neoplasms (Pancreatic Cancer)
01/2000
Drug/Important Bio-Agent (IBA)
5
Peptides (Polypeptides)
IBA
12/2007 - 02/2000
5
Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))
IBA
12/2001 - 01/2000
4
Chelating Agents
IBA
05/2012 - 10/2005
3
Monoamine Oxidase (MAO)
IBA
05/2012 - 10/2004
3
Iron
IBA
01/2006 - 10/2004
3
(VIP-neurotensin) hybrid antagonist
IBA
12/2001 - 01/2000
2
tuftsin-phosphorylcholine
IBA
01/2018 - 04/2016
2
Amyloid beta-Peptides
IBA
05/2012 - 01/2000
2
Gonadotropin-Releasing Hormone (GnRH)
FDA Link
09/2006 - 08/2001
2
Neuroprotective Agents
IBA
01/2006 - 10/2005
2
Metals
IBA
01/2006 - 10/2005
2
Deferoxamine (Desferal)
FDA Link
Generic
01/2006 - 01/2006
2
Oxidopamine (6 Hydroxydopamine)
IBA
01/2006 - 01/2000
2
Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)
IBA
12/2001 - 07/2001
2
Insulin (Novolin)
FDA Link
08/2000 - 06/2000
1
Methylprednisolone
FDA Link
Generic
01/2018
1
anti-dsDNA autoantibody
IBA
01/2018
1
Phosphates (Orthophosphate)
IBA
01/2018
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2018
1
Collagen
IBA
04/2016
1
Interleukin-10 (Interleukin 10)
IBA
04/2016
1
Tuftsin
IBA
04/2016
1
Antibodies
IBA
04/2016
1
Interleukins
IBA
04/2016
1
Antioxidants
IBA
05/2012
1
Acetylcholinesterase
IBA
05/2012
1
Antigens
IBA
12/2007
1
Interferons
IBA
12/2007
1
Immunodominant Epitopes
IBA
12/2007
1
Palmitic Acid (Hexadecanoic Acid)
IBA
09/2006
1
Hormones (Hormone)
IBA
09/2006
1
Clioquinol (Vioform)
FDA Link
01/2006
1
Copper
IBA
01/2006
1
1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
IBA
01/2006
1
rasagiline (Azilect)
FDA Link
01/2006
1
Selegiline (E250)
FDA Link
Generic
01/2006
1
Etorphine (M99)
IBA
01/2006
1
Neuropeptides
IBA
10/2001
1
LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)
IBA
08/2001
1
Photosensitizing Agents (Photosensitizers)
IBA
08/2001
1
Doxorubicin (Adriamycin)
FDA Link
Generic
07/2001
1
Paclitaxel (Taxol)
FDA Link
Generic
07/2001
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
12/2000
1
Lipopolysaccharides
IBA
10/2000
1
Endotoxins
IBA
10/2000
1
Glucose (Dextrose)
FDA Link
Generic
08/2000
1
Vanadates (Orthovanadate)
IBA
08/2000
1
Phlorhizin
IBA
08/2000
1
Isophane Insulin (NPH Insulin)
FDA Link
06/2000
1
Blood Glucose (Blood Sugar)
IBA
05/2000
1
Vanadium
IBA
05/2000
1
Cardiolipins (Cardiolipin)
IBA
04/2000
1
Monoclonal Antibodies
IBA
04/2000
1
DNA (Deoxyribonucleic Acid)
IBA
04/2000
1
Proteins (Proteins, Gene)
FDA Link
02/2000
1
Glutathione (Reduced Glutathione)
IBA
01/2000
1
Buthionine Sulfoximine
IBA
01/2000
1
1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)
IBA
01/2000
1
Dopamine (Intropin)
FDA Link
Generic
01/2000
Therapy/Procedure
6
Therapeutics
01/2018 - 01/2000
1
Drug Therapy (Chemotherapy)
08/2001